A comprehensive procedure for antiviral inhibitor discovery using EV71 as an example.

Area of Science:

• Virology
• Drug Discovery
• Molecular Biology

Background:

• Rising prevalence of chronic viral infections and emerging viral threats necessitates novel antiviral therapies.
• Antiviral drug resistance limits current treatment options, increasing the demand for new strategies.
• Understanding viral molecular mechanisms offers opportunities for targeted antiviral agent development.

Purpose of the Study:

• To introduce a comprehensive system for leading antiviral compound discovery.
• To demonstrate the system's utility using enterovirus 71 (EV71) as a model system.
• To facilitate the development of new antiviral agents targeting viral or host factors.

Main Methods:

• Development of a comprehensive discovery system.
• Application of the system to enterovirus 71 (EV71) for compound screening.
• Utilizing insights into molecular mechanisms of viral infection for target identification.

Main Results:

• A functional system for leading compound discovery was established.
• The system was successfully applied to EV71, demonstrating its potential for identifying antiviral candidates.
• The approach allows for the identification of compounds targeting key viral or host components.

Conclusions:

• The developed system provides a robust platform for discovering novel antiviral compounds.
• Targeting molecular mechanisms of viral replication is a promising strategy for new antiviral development.
• This work contributes to addressing the urgent need for effective antiviral therapies against challenging viral infections like EV71.